China Nepstar Chain Drugstore to Report First Quarter 2014 Financial Results on May 29, 2014
PR Newswire - Fri May 09, 4:00AM CDT
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company"
China Nepstar Chain Drugstore Filed 2013 Annual Report on Form 20-F
PR Newswire - Tue Apr 22, 10:09AM CDT
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company"
Rite Aid Reaches 52-Week High on Q4 Earnings Beat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 11, 8:00AM CDT
Rite Aid posted better-than-expected fourth-quarter fiscal 2014 results.
China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2013 Financial Results
PR Newswire - Fri Mar 28, 2:00AM CDT
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company"
Buy-Rated Dividend Stocks: Top 3 Companies: NPD, BKCC, CLCT
at The Street - Mon Mar 10, 10:30AM CDT
These 3 dividend stocks are rated a Buy by TheStreet
China Nepstar Chain Drugstore to Report Fourth Quarter and Fiscal Year 2013 Financial Results on March 28, 2014
PR Newswire - Fri Mar 07, 6:00AM CST
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company"
3 Buy-Rated Dividend Stocks Taking The Lead: NPD, PZN, AB
at The Street - Thu Feb 27, 10:30AM CST
These 3 dividend stocks are rated a Buy by TheStreet
Rite Aid Q3 Earnings in Line - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Dec 20, 7:50AM CST
Rite Aid posted third-quarter fiscal 2014 earnings of 4 cents per share, which was in line with the Zacks Consensus Estimate.
China Nepstar Chain Drugstore (NPD) Jumps: Stock Rises 7.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Dec 18, 7:21AM CST
China Nepstar Chain Drugstore Ltd. (NPD) was a big mover last session, as the company saw its shares rise by over 7% on the day.
Tomorrow's Ex-Dividends To Watch: NPD, DHG, CII, BKCC, IGT
at The Street - Tue Dec 17, 9:00AM CST
NPD DHG CII BKCC IGT are going ex-dividend tomorrow, Wednesday, Dec. 18, 2013, 5:00 AM ET
China Nepstar Chain Drugstore Ltd's board to pay USD0.32 per ADS annual dividend
M2 - Tue Nov 26, 6:58AM CST
The board of directors of China Nepstar Chain Drugstore Ltd (NYSE:NPD), a retail drugstore chain in China, on Tuesday declared its annual cash dividend of USD0.32 per American Depositary Share (ADS).
China Nepstar Chain Drugstore Announces Annual Dividend
PR Newswire - Tue Nov 26, 1:00AM CST
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company"
China Nepstar Chain Drugstore Reports Third Quarter 2013 Financial Results
PR Newswire - Tue Nov 26, 1:00AM CST
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company"
Rite Aid Q2 Earnings Beat, Stock Hits 5-Yr High - Analyst Blog
Mark Vickery - Zacks Investment Research - Fri Sep 20, 7:30AM CDT
Driven by higher adjusted EBITDA and lower interest expenses, Rite Aid posted a quarterly profit for the fourth consecutive quarter.
China Nepstar Chain Drugstore swings to loss in Q2 2013
M2 - Fri Aug 30, 8:24AM CDT
China Nepstar Chain Drugstore Ltd (NPD), a retail drugstore chain in China, on Thursday reported a net loss of CNY3.9m, or CNY0.04 per basic and diluted ADS, for the second quarter of 2013, ended 30 June 2013.
China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2013 Financial Results
PR Newswire - Thu Aug 29, 3:00AM CDT
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company"
China Nepstar Chain Drugstore Ltd. to Report Second Quarter 2013 Financial Results
PR Newswire - Thu Aug 08, 5:00AM CDT
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company"
Research and Development Forecast of China Pharmaceutical Chain Market Report, 2013-2017
M2 - Fri Jul 26, 8:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/z55jsz/research_and) has announced the addition of the "Research and Development Forecast of China Pharmaceutical Chain Market, 2013-2017" report to their offering. Firstly the report makes the overview of China pharmaceutical circulation industry's development, makes the introduction and analysis of the industry's management system and related policies and further points out the future investment opportunities of China's pharmaceutical circulation field. Secondly it makes the deep analyses of the development status quo, advantages, existing problems and access barriers etc. of the pharmaceutical chain industry as well as the special chapter analysis of China's top 100 pharmaceutical retail enterprises. Lastly it makes the future development forecast of China's pharmaceutical chain, which can provide the decisive reference for the investment in the industry. Influencing by the rapid development of China's pharmaceutical industry and the increasing aging population, the pharmaceutical retail market develops rapidly, chain enterprises continuing the expansion and the number of the pharmacies increasing continuously. By the end of 2012, the sales amount of China's top 100 pharmaceutical retail enterprises reached CNY 87.877 billion, up 17.51% compared to last year, with the share of 39.06% in China's pharmaceutical retail market. The total number of branches of the top 100 enterprises' direct sale-stores was 50,418 in 2012, up 4.96% year on year. In the increasing market competition, the pharmaceutical retail market maintains the rapid development situation. With the promotion of the construction of Two Networks (pharmaceutical supply network and pharmaceutical monitoring network) and the reform of new cooperative medical care system in the rural areas, the rural pharmaceutical market gets the development, becoming the key areas of the future expansion of chain drugstores. With gradual perfect and comprehensive implementation of the new medical care system reform, China's pharmaceutical retail market ushers the wonderful development opportunity, the pharmaceutical chain industry entering the period of the strategic opportunity with brand development prospect. During the 12th-Five-Year period, the proportion of chain drugstores will account for two thirds of the total drugstores and will be equipped comprehensively with licensed pharmacists. Key Topics Covered: 1. Development of China's Pharmaceutical Circulation Industry 2. Overview of China's Pharmaceutical Chain Industry 3. Special Analysis of China's Top 100 Pharmaceutical Retail Enterprises 4. Key Enterprises of China's Pharmaceutical Chain 5. Future Development of China's Pharmaceutical Chain Companies Mentioned - China Nepstar Chain Drugstore Co., Ltd. - Chongqing Peace Pharmacy Chain Co., Ltd. - Chongqing Tongjunge Pharmacy Chain Store Co., Ltd. - Guangdong Dashenlin Chain Drugstore Co., Ltd. - Hubei Tongjitang Pharmacy Co., Ltd. - Liaoning CDFY Pharmacy Chain Co., Ltd. - Sinopharm Holding Guoda Drugstores Co., Ltd. - Yunnan Hongxiang Yixintang Pharmaceutical Co., Ltd. For more information visit http://www.researchandmarkets.com/research/z5...search_and
BCOM, BEAT, NPD, EXXI, HF, TA Are Seasonally Ripe To Go Down In the Next Five Weeks
M2 - Mon Jul 08, 4:56AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of B Communications Ltd (NASDAQ:BCOM), CardioNet Inc (NASDAQ:BEAT), China Nepstar Chain Drugstore Ltd (NYSE:NPD), Energy XXI (Bermuda) Ltd (NASDAQ:EXXI), Hanfeng Evergreen Inc (NYSE:HF), TransAlta Corp (AMEX:TA) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: